Player FM - Internet Radio Done Right
40 subscribers
Checked 18d ago
تمت الإضافة منذ قبل six عام
المحتوى المقدم من Anuj Desai. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة Anuj Desai أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
Player FM - تطبيق بودكاست
انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
المدونة الصوتية تستحق الاستماع
برعاية
O
Our Skin: A Personal Discovery Podcast


1 You Are Your Longest Relationship: Artist DaQuane Cherry on Psoriasis, Art, and Self-Care 32:12
32:12
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب32:12
DaQuane Cherry was once the kid who wore a hoodie to hide skin flare-ups in school. Now he’s an artist and advocate helping others feel seen. He reflects on his psoriasis journey, the power of small joys, and why loving yourself first isn’t a cliché—it’s essential. Plus, a deep dive into the history of La Roche-Posay’s legendary spring. See omnystudio.com/listener for privacy information.…
The Cannabis Conversation | Medical Cannabis | CBD | Hemp explicit
وسم كل الحلقات كغير/(كـ)مشغلة
Manage series 2522512
المحتوى المقدم من Anuj Desai. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة Anuj Desai أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
The cannabis industry is gaining traction across the world, as new medical discoveries, and multi-billion dollar businesses are grabbing the headlines on a regular basis. Experts predict the worldwide industry could be worth in excess of $300bn within 10 years, with Europe forming the biggest market within that, so there's plenty to get excited about. I want to find out more about what's happening, and I'm bringing you along for the ride. Join me - Anuj Desai - as I speak to a wide variety of guests who are helping to shape this nascent sector. Having interviewed over 100 guests, including patients, lawyers, doctors, scientists, entrepreneurs, investors and many more, we discover how, and why, this much maligned and misunderstood plant is giving birth to a huge global business.
…
continue reading
192 حلقات
وسم كل الحلقات كغير/(كـ)مشغلة
Manage series 2522512
المحتوى المقدم من Anuj Desai. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة Anuj Desai أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
The cannabis industry is gaining traction across the world, as new medical discoveries, and multi-billion dollar businesses are grabbing the headlines on a regular basis. Experts predict the worldwide industry could be worth in excess of $300bn within 10 years, with Europe forming the biggest market within that, so there's plenty to get excited about. I want to find out more about what's happening, and I'm bringing you along for the ride. Join me - Anuj Desai - as I speak to a wide variety of guests who are helping to shape this nascent sector. Having interviewed over 100 guests, including patients, lawyers, doctors, scientists, entrepreneurs, investors and many more, we discover how, and why, this much maligned and misunderstood plant is giving birth to a huge global business.
…
continue reading
192 حلقات
كل الحلقات
×
1 EPISODE #194 Examining Medical Cannabis in Practice with Franjo Grotenhermen, M.D., Chairperson at IACM 33:48
33:48
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب33:48
On the latest episode of The Cannabis Conversation, we speak with Dr. Franjo Grotenhermen, Chairperson at the International Association of Cannabinoid Medicines (IACM). We explore his journey into cannabis medicine, its diverse uses, and the challenges of its regulation. Together, we look at the importance of patient experiences and the need for a balance between clinical trials and real-world experiences. We also examine the risk profile of cannabis, potential side effects, contraindications, and interactions with other medications. The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ About Franjo Grotenhermen M.D. Franjo Grotenhermen graduated in medicine and received his doctorate in Cologne. His fields of practice included internal medicine, surgery and naturopathy. He is head of the Centre for Cannabis Medicine in Steinheim (NRW) with a focus on therapy with cannabis and cannabinoids. Grotenhermen is Executive Director of the Arbeitsgemeinschaft Cannabis als Medizin e.V. (ACM) (since 1997), Executive Director of the International Alliance for Cannabinoid Medicines (IACM) (since 2000) and author of the IACM-Bulletin, which is published fortnightly in several languages on the IACM website. Grotenhermen is an employee of the Cologne-based nova Institute, co-owner of Endoxo GmbH (founded in 2019), a company that produces CBD and other hemp products. He is a lecturer at Dresden International University. He is Chief Medical Advisor of canncura, an internet platform for telemedicine in the field of cannabis and cannabinoids. He is a member of the Scientific Advisory Board of the journals Cannabis and Cannabinoid Research, edited by Prof. Daniele Piomelli at Mary Ann Liebert Publishing. He received the following awards: Hanf-Preis 1999 of Cannabusiness, IACM 2011 Special Award, ICBC 2018 Lifetime Achievement Award, Robert Newman Memorial Award 2018 of Akzept e.V., Honorary Award GFS-Award 2021 of Gemeinnützige Forschungsvereinigung Saluplanta e.V. Resources Connect with Franjo on LinkedIn: linkedin.com/in/franjo-grotenhermen-65624b19b IACM’s Website: https://cannabis-med.org/…

1 EPISODE #193: Investment in the European Cannabis Industry with William Muecke & Daniel Grözinger 55:30
55:30
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب55:30
On the latest episode of The Cannabis Conversation, we speak with William Muecke of Artemis Growth Partners & Daniel Grözinger of Park Lane Capital. We look at the European Cannabis Industry from an investment perspective, including the benefits of the legal cannabis market in Germany and France, the potential for mergers and acquisitions in Europe, and Will and Daniel’s thoughts on what’s needed to succeed in this sector in the next few years. The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ About William Muecke Will Muecke is the Managing Member at Artemis Growth Partners, a private equity firm with $390 million in assets, specializing in ESG and impact investments within the global cannabis industry. He also co-founded CoreCo Private Equity, an ESG-focused fund, recognized as a "Best for the World" fund in 2017, with backing from institutions like the IFC/World Bank and European family offices. Previously, he served as global co-head of healthcare services at Goldman, Sachs & Co. in New York, with extensive networks across Europe, the United States, and Latin America. Currently, he holds the position of Chief Investment Officer at Artemis Growth Partners in London. About Daniel Grözinger Daniel Grözinger, a Partner at Parklane Capital in Germany, is a seasoned M&A expert with a focus on the tech sector. In 2021, he expanded his expertise into the cannabis market and played a pivotal role in the sale of Four 20 Pharma to Curaleaf in 2022. With a background in over 75 M&A deals, Daniel is also a serial entrepreneur. Notably, he co-founded getgo.de, an online ticketing industry leader, and sold it to CTS Eventim AG. He then managed two business units at CTS, generating over 500 million EUR in revenue. In 2003, he founded uniquedigital, a top-ranked online marketing agency, later acquired by Syzygy AG in 2008. Daniel has a history of founding and building customer-focused companies, including verwandt.de, Farbflut Entertainment, Emporis, and Animod, among others. He has also invested in various internet companies and startups as a business angel, including Prezi.com and Fiverr, before joining Parklane Capital in 2014. Resources Connect with William on LinkedIn: https://www.linkedin.com/in/wmuecke Connect with Daniel on LinkedIn: https://www.linkedin.com/in/groezinger/ Artemis Growth Partners’ Website: www.artemisgrowth.com Parklane Capital’s Website:…

1 EPISODE #192: The first cannabis flower prescription on the NHS with Mike Roberts 26:33
26:33
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب26:33
On the latest episode of The Cannabis Conversation, we’re joined by Mike Roberts, a medical cannabis patient in the UK. We explore Mike’s journey with cannabis, the potential benefits of incorporating cannabis into cancer treatment plans, and his trailblazing story of becoming the first patient to successfully get his cannabis flower prescription reimbursed by the NHS. The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ About Mike Roberts Mike Roberts is a special needs teacher, musician, and father. His interests include photography, chemistry, and medical cannabis. In 2021 at the age of 43, Mike was diagnosed with incurable cancer. In 2023 he became the first person in the UK to receive NHS funding for cannabis flower. Resources Connect with Mike on LinkedIn: https://www.linkedin.com/in/mike-roberts-42a46122b Mike’s Website: https://www.michaelrobertstutoring.com/…

1 EPISODE #191: Cannabis Regulation in the UK - Update with Robert Jappie, Partner at Fieldfisher 32:43
32:43
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب32:43
On the latest episode of The Cannabis Conversation, we’re joined by Robert Jappie of Fieldfisher - a European Law Firm with a strong Life Sciences practice. We explore cannabis regulation in the UK, and overcoming opposition in the industry as well as the wider challenges facing the medical cannabis industry, including political support and lack of research and funding. The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ About Robert Jappie Robert Jappie is a partner at Fieldfisher, a European Law Firm with a focus on Life Sciences and Tech industries. He is a Regulatory Lawyer and specialises in emerging Life Sciences sectors, providing regulatory and commercial representation to a range of nascent industries. He has particular expertise in Cannabis Regulation, Psychedelic Medicines, Food/Agri-Tech and Healthcare, and is considered one of the foremost legal authorities in the UK on the UK and European cannabis industry. Robert has advised many of the well-established cannabis companies operating in the UK and EU, and has provided regulatory support for a number of M&A and Capital Markets transactions. Resources Connect with Robert on LinkedIn: https://www.incegd.com/en/our-team-london/robert-jappie Fieldfisher’s Website: https://www.fieldfisher.com/en…

1 EPISODE #190: Exploring Cannabis Use Disorder with Will Lawn of King’s College London 41:05
41:05
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب41:05
On the latest episode of The Cannabis Conversation, we’re joined by Will Lawn of King’s College London - an internationally renowned university delivering exceptional education and world-leading research. We explore cannabis use disorder, the concept of addiction as a spectrum, as well as the biological underpinnings of cannabis use disorder, potential treatment options, and the link between cannabis and tobacco use. The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ About Will Lawn Dr Will Lawn is a psychology lecturer and psychopharmacology researcher at King's College London. By taking a multi-disciplinary approach, Will investigates the short and long-term effects of recreational drugs on the human mind and brain, as well as researching the therapeutic applications of cannabinoids and ketamine. Resources Connect with Will Lawn on LinkedIn: https://www.linkedin.com/in/will-lawn-51724b215 King’s College London’s Website: https://www.kcl.ac.uk/…

1 EPISODE #189: Patient-Centred Medical Cannabis with Carly Barton, Alex Fray, & Charlie Price 40:57
40:57
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب40:57
Can the legal cannabis industry provide affordable and high-quality medicine for patients? On the latest episode of The Cannabis Conversation, we’re joined by my good friends, Carly Barton from Cancard - the largest patient advocacy group in Europe - and Alex Fray and Charlie Price GLO - a British medical cannabis company headquartered on the Isle of Man. We explore the importance of community and patient-centred approaches to medical cannabis, as well as controlling the entire supply chain, from cultivation to distribution, in order to provide patients with choice. Support the crowdfund raise, help them grow, and let's improve patient access to quality medicine! 🌿 https://www.seedrs.com/grow-organics The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ About Alex Fray Alex has held a range of positions including CEO, CFO and COO in regulated industries over the last 20 years. He is currently a Director within the Isle of Man Government's Department for Enterprise, advising the Government on cannabis and biomedical sectors. Having worked in both start-up and SME environments, he understands how to grow businesses with great culture. He is a qualified accountant with IPO experience. About Charlie Price Charlie has an academic background with a BSc, MSc and 6yrs PhD research in integrated farming and Ecotoxicology. A proven entrepreneur having co-founded both a £50m turnover renewable energy imports business as well as a social enterprise that developed horticultural projects in 5 continents and over 20 countries. About Carly Barton Carly Barton, a former arts lecturer, exhibited at Tate and Saatchi gallery. Health issues led her to discover Medical Cannabis as a more effective substitute for treating Fibromyalgia, lupus, and post-stroke Neuropathy. Now, she advocates for patient access to medical cannabis, advising UK and international advocacy groups. As the first UK patient prescribed herbal cannabis privately since the 2018 law change, she strives for NHS prescriptions to set a precedent. Carly initiated Carly's Amnesty and co-founded Cancard, connecting police, doctors, patients, and MPs to ease fears of interference. Cancard, Europe's largest patient advocacy group, represents over 80,000 registered medical cannabis patients. Carly, dedicated to advocacy, is currently Chief Community Officer at Grow Lab Organics. Resources Connect with Alex on LinkedIn: https://www.linkedin.com/in/alex-fray-a1934a11 Connect with Charlie on LI: https://www.linkedin.com/in/charlie-price-2290901b5 Connect with Carly on LI: https://www.linkedin.com/in/carly-barton-11a098181 Cancard’s Website: https://cancard.co.uk/ GLO’s Website: https://growlaborganics.com/…

1 EPISODE #188: Cannabis Cowboys: The Juicy Fields Scandal with Nicolas Martin & Andreas Becker, Journalists of DW 32:46
32:46
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب32:46
On the latest episode of The Cannabis Conversation, we’re joined by Nicolas Martin & Andreas Becker journalists for DW in Germany, and presenters of the Cannabis Cowboys podcast series. We discuss the Juicy Fields scandal, an investment scam targeting investors in the medical cannabis industry, and what Nicolas and Andreas discovered as they investigated the story. Please check out the Cannabis Cowboys podcast here: DW: https://www.dw.com/en/cannabis-cowboys/program-62614055 Apple: https://podcasts.apple.com/au/podcast/cannabis-cowboys/id1662329269 Spotify: https://open.spotify.com/show/4Yfw49Kkb91WQUe48ES5SZ The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ About Nicolas Martin Nicolas Martin is a freelance editor, writer and presenter at the business desk of DW, Germany's international broadcaster. He also works as a trainer and consultant for national and international podcast projects. In 2017, he started to report on the cannabis industry and was astonished when, in 2021, he first heard about JuicyFields' e-growing offer. About Andreas Becker Andreas Becker is a senior editor, reporter, writer and presenter at the business desk of DW. His focus is on international trade and finance, and he's also covering development politics. This podcast is his first foray into the business side of Cannabis. Resources Connect with Nicolas on LinkedIn: https://www.linkedin.com/in/nmmedia Connect with Andreas on LinkedIn: https://www.linkedin.com/in/andreas-becker-21b581155…

1 EPISODE #187: How can ESG help cannabis companies? with Leonid Kotlyar, Co-Founder and Managing Director of DéWarrior 38:52
38:52
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب38:52
On the latest episode of The Cannabis Conversation, we’re joined by Leonid Kotlyar, Co-Founder and Managing Director of DéWarrior Unlimited B.V. - a sustainability-focused managing consulting firm headquartered in The Netherlands. We explore the intersection of sustainability and the cannabis industry, the challenges of applying ESG to the cannabis sector, as well as the differences between the North American and European cannabis industries. The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ About Leonid Kotlyar Leonid (Leo) Kotlyar is the co-founder and Managing Director of DéWarrior Unlimited B.V., a sustainability focused managing consulting firm headquartered in The Netherlands. DéWarrior ( www.dewarrior.com ) offers its advisory service in ESG, M&A, and Management Consulting, utilizing comprehensive data collection and advanced modeling techniques to drive integrated decision making. Prior to founding DéWarrior, Leo spent 12 years in institutional equity derivatives, building and delivering the early cornerstones of ESG to his customer base of pension plans, insurers, and sovereign wealth funds. Resources Connect with Leo on LinkedIn: https://www.linkedin.com/in/leonid-d%C3%A9warrior-925747132 DéWarrior Unlimited B.V.: https://www.dewarrior.com/…

1 EPISODE #186: Cannabis in Switzerland with Luc Richner, CEO of Cannavigia 40:52
40:52
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب40:52
On the latest episode of The Cannabis Conversation, we speak with Luc Richner, CEO of Cannavigia - Europe’s pioneer compliance software for businesses to trace, secure and simplify transactions along the entire cannabis supply chain. We explore Switzerland's approach to cannabis legalisation and the pilot projects they are implementing, the importance of supply chain management as well as the challenges of international movement of cannabis goods. The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ About Luc Richner Luc Richner was born in Switzerland, but raised in Asia. After finishing his education and studies in Switzerland, Luc followed his calling to be an entrepreneur. Based on his experience in logistics and management, Luc's first venture was dedicated to upcycling used materials to high-end furniture. In the following years, he ventured into the global logistics industry, established an expert consultancy to "bridge worlds" and has created a unique, local and sustainable farm to table restaurant in Bali, Indonesia. Back in Switzerland he successfully finished the first Executive MBA Digital Leadership program at the HWZ, “University of Applied Sciences” in Zurich. Based on his experience and extraordinary knowledge about highly efficient and transparent supply chains and logistics, Luc Richner has founded Vigia AG – a software platform for more transparency and compliance in the global and local supply chains, with its first dedicated industry being cannabis. Cannavigia is Europe’s pioneer compliance software for businesses to trace, secure and simplify transactions along the entire cannabis supply network. Resources Connect with Luc on LinkedIn: https://www.linkedin.com/in/luc-richner-ab30845b Cannavigia’s Website: https://cannavigia.com/…

1 EPISODE #185: European Cannabis Industry Update with Nikolaas Faes, Senior Research Analyst of Bryan Garnier 33:03
33:03
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب33:03
On the latest episode of The Cannabis Conversation, we’re joined by Nikolaas Faes, a senior research analyst at Bryan, Garnier & Co - an independent full-service investment bank for European healthcare and technology-led companies and their investors. We discuss the size and potential growth of the European Cannabis market, the different sub-sectors such as CBD and medical cannabis, and the challenges of investing in an industry heavily reliant on regulatory change. The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ About Nikolaas Faes As a senior research analyst at Bryan Garnier, Nik Faes examines not only the global cannabis sector but also the fields of alcoholic beverages and AgriTech. Based in London, he has worked over the past 35 years for a number of international financial institutions and has been a professor in financial analysis, fund management and financing. Resources Connect with Nik on LinkedIn: https://www.linkedin.com/in/nikolaas-faes-42b34b28 Bryan Garnier Website: https://www.bryangarnier.com/…

1 EPISODE #184: Understanding Cannabis Seeds with Jorge Cervantes, Dr. Gary Yates, & Stefan Meyer 42:16
42:16
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب42:16
On the latest episode of The Cannabis Conversation, we’re joined by Jorge Cervantes, Dr. Gary Yates, & Stefan Meyer. We explore some of the different ways to grow cannabis, focusing on seeds, as well as discussing some of their pros and cons, and we discuss the huge commercial trade in seeds. The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ About Jorge Cervantes Jorge Cervantes’ public career spans 39 years. His books and DVDs (50 total) are published under his given name, George F. Van Patten and pseudonym, Jorge Cervantes, in Dutch, English, French, Italian, Japanese, German, Russian, and Spanish. Self-publisher, Cervantes’ (Indoor) Marijuana Horticulture book was christened “the Grow Bible” in 2000 by indoor, greenhouse and outdoor growers. His knowledge and hands-on experience inspired millions of growers worldwide to apply simple, effective techniques to grow more and better cannabis. About Dr. Gary Yates Dr. Gary Yates is a well-rounded plant scientist with experience in nearly all aspects of plant life. Dr. Yates, as a world-class genetic problem solver, offers scientific know-how aspects that are normally lacking in cultivation advice. Dr. Yates also brings to the forefront knowledge of the most recent technology in infrastructure/equipment and scientific advances, as well as pathogen mitigation and pest management. He is an experienced micro-grower and plant health assessor known for his ability to maximize limited resources to produce outcomes that exceed expectations. Having collected his first harvest over 20 years ago and before embarking on a career in science, Gary has had a keen eye on the progression of the medical use of Cannabis, including its biochemistry, genetic development, and cultivar suitability for many years. About Stefan Meyer Stefan Martin Meyer, MBA, was raised in the Italian side of Switzerland, near the city of Lugano. He then moved to Spain, where he co-founded Phytoplant Research SL, which was granted the first research license for medical cannabis in Spain in 2012. While there, he got various R&D grants from the European Union for projects related to cannabinoids and medicine and published results in high-impact scientific journals. In 2019 Stefan joined Plena Global Holding Inc (Canada) as Chief Strategy Officer, where he has been leading a project licensed to grow medicinal cannabis in Colombia. In 2020 Stefan founded Phytoflow GmbH, a Swiss-based company providing experience-driven strategic business advice to companies active in the medical cannabis sector. Stefan has worked with Jorge for over two decades and, like him, is a huge cannabis aficionado. Resources: Connect with Jorge on LinkedIn: https://www.linkedin.com/in/jorge-cervantes-cannabis-author Connect with Gary on LinkedIn: https://www.linkedin.com/in/gary-yates-40176b92 Connect with Stefan on LinkedIn: https://www.linkedin.com/in/stefan-meyer-cbd…

1 EPISODE #183: Remembering Professor Raphael Mechoulam with Zach Klein, Film Director and Cannabis Researcher 36:27
36:27
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب36:27
On the latest episode of The Cannabis Conversation, we’re joined by Zach Klein, documentary maker and producer of "The Scientist," a film about Professor Raphael Mechoulam. We pay tribute to the life and work of Professor Mechoulam, a pioneering scientist in the field of cannabis research, also dubbed ‘The Godfather of Cannabis Research’. Prof Mechoulam passed away on March 9, 2023, at the age of 92, leaving behind a legacy that has had a profound impact on the study of cannabinoids and their therapeutic potential. Please check out the film here - https://www.youtube.com/watch?v=csbJnBKqwIw The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ About Zach Klein Zach Klein is a film director and cannabis researcher, who has been at the forefront of the medical cannabis movement. His documentary "Prescribed Grass" (2009), played a significant role in Israel accepting the medical use of cannabis. He is one of the founding fathers of the cannabis medical use programs. He has introduced the use of cannabis in nursing homes, which has improved the quality of life of the elderly. Later, he produced the documentary "The Scientist," which focuses on the life and work of Raphael Mechoulam, the “Grandfather” of cannabis research. Resources ‘The Scientist’ Film: https://www.youtube.com/watch?v=csbJnBKqwIw Zach Klein’s website: http://zaklein.com/home/ Dr. Mechoulam’s Wikipedia Page: https://en.wikipedia.org/wiki/Raphael_Mechoulam…

1 EPISODE #182: Data Driven Decisions in Cannabis with Jeffrey Graham, CEO of Pistil Data 33:07
33:07
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب33:07
On the latest episode of The Cannabis Conversation, we speak with Jeffrey Graham, CEO of Pistil Data - providers of data and analytics to cannabis brands and retailers. We explore cannabis consumer patterns, pricing strategies for retailers, and how the market is evolving, as well as the cannabis industry in North America in general. The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ About Jeffrey Graham Jeffrey Graham is CEO of Pistil Data, which provides data and analytics to cannabis brands and retailers. He has built data science teams at The New York Times, Google and Twitter, where he was VP of Market Insight. Prior to founding Pistil, Jeffrey led business intelligence at NorCal Cannabis Company. Resources Connect with Jeffrey on LinkedIn: https://www.linkedin.com/in/jeffreygraham1 Pistil Data’s Website: https://www.pistildata.com/…

1 EPISODE #181: Why most CBD oil has low bioavailability and how to change that with Dr. Sung Min Pyo, Head of Laboratory - Enabling Pharma Excipients for BASF 36:36
36:36
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب36:36
How effective is CBD oil? On the latest episode of The Cannabis Conversation, we’re joined by Dr Sung Min Pyo - Head of Laboratory - Enabling Pharma Excipients for BASF. A 2018 report from the World Health Organisation (WHO) estimated the bioavailability from oral consumption of CBD to be only 6% (WHO Technical Report Series 1013 - https://www.who.int/publications/i/item/9789241210225 ) We explore the reasons behind this estimate and discuss the bioavailability, absorption, and solubility of CBD, alongside some potential solutions to improve its uptake in the body. The Cannabis Conversation is sponsored by EVO NXT - the business festival for Next Generation Products (NGP). The festival offers: modern live communication with experts and big-name speakers, key note talks, summits, workshops, panel dicussions and entertainment! More information: www.evo-nxt.com Secure your ticket now: www.evo-nxt.com/ticketshop About Dr. Sung Min Pyo Dr. Sung Min Pyo holds a PhD in Pharmacy and has dedicated her career to making the world a healthier place. As an expert in the field of bioavailability, she develops novel drug delivery systems that fundamentally improve the uptake and thus the efficacy of drugs in the body. As a consultant to pharmaceutical companies and public institutions, and as a head of laboratory at BASF, she has an in-depth understanding of how to bring innovative ideas to the finished product that truly improves people's lives. Resources Connect with Dr. Sung Min Pyo on LinkedIn: https://www.linkedin.com/in/sung-min-pyo…

1 EPISODE #180: Cannabis in Malta with Nick Pateras of Materia & Andrew Bonello of ReLeaf Malta 27:20
27:20
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب27:20
On the latest episode of The Cannabis Conversation, we’re joined by Nick Pateras of Materia and Andrew Bonello of ReLeaf Malta. We discuss Malta’s approach to cannabis, social clubs, home growing in its domestic market as well as how Malta fits into the European cannabis supply chain. The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ On the podcast I mentioned Breaking Convention taking place in Exeter in April. Please join me there by getting a ticket here - https://www.tickettailor.com/events/breakingconvention/807898/ About Nick Pateras Nick Pateras is Managing Director, Europe at Materia, where he oversees the company’s operations across Germany, Malta and the UK. Materia is an EU GMP certified manufacturer and distributor of medical cannabis and CBD products across the burgeoning European market. Previously, Nick served as Vice President, Strategy at Lift & Co., Canada’s leading cannabis education and insights platform. He is a regular speaker at cannabis conferences across North America and Europe and taught the Cannabis Business Fundamentals course at George Brown College in Toronto in 2018-19. Prior to his time in cannabis, Nick spent several years in the pharmaceutical sector with Johnson & Johnson Inc, managing various category-leading OTC and Health & Beauty businesses. About Andrew Bonello Andrew Bonello is the President of ReLeaf Malta and, has since 2019, worked tirelessly to represent the voice of cannabis consumers in Malta. Andrew has been actively meeting various local actors and international experts to discuss issues related to cannabis, human rights and public health, more specifically advocating for a more just, humane and non-criminal approach. Today, Andrew remains committed to push forward for a truly decriminalized and regulated approach to cannabis, placing the well-being of consumers at the helm of every decision. Resources Connect with Nick on LinkedIn: https://www.linkedin.com/in/nickpateras/ Follow Nick on Twitter: https://twitter.com/nick_pateras Materia’s Website: https://www.materia.global/ Connect with Andrew on LinkedIn: https://www.linkedin.com/in/andrew-bonello-73392629 Follow Andrew on Twitter: https://twitter.com/Andrew_Bonello Follow ReLeaf Malta on Instagram: https://www.instagram.com/releafmalta/…
T
The Cannabis Conversation | Medical Cannabis | CBD | Hemp

1 EPISODE #179: Cannabis in Spain with Carola Pérez, President of the Observatorio Español de Cannabis Medicinal and Founder of the Patient Association - dosemociones 35:56
35:56
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب35:56
On the latest episode of The Cannabis Conversation, we’re joined by Carola Pérez, president of the Observatorio Español de Cannabis Medicinal, and founder of the patient association - dosemociones. We explore what’s happening with medical cannabis in Spain as well as recreational use, and how the social clubs work in Spain. The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ About Carola Pérez Carola is the president of the Observatorio Español de Cannabis Medicinal and founder of the patient association dosemociones. She has been working tirelessly since 2014 for patients' rights, helping and advising on the properties of medical cannabis in Spain. Carola is also chair of the IACM Patient Council, an international coalition of patients’ organizations that have gathered together to help give a voice to patients the world over and to work together in order to protect their rights and interests in the ever-developing world of medicinal cannabis. Resources Connect with Carola on LinkedIn: https://www.linkedin.com/in/carola-p%C3%A9rez-73890ab5 dosemociones’s Website: http://www.dosemociones.com/ Follow Carola on Instagram: https://www.instagram.com/carolaperez/ Follow Carola on Twitter: https://twitter.com/carolaperez…
T
The Cannabis Conversation | Medical Cannabis | CBD | Hemp

1 EPISODE #178: Cannabis in Mexico with José Lugardo Espejel & Anndrea Hermann from HGrown Consulting 32:04
32:04
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب32:04
On the latest episode of The Cannabis Conversation, we speak with José Lugardo Espejel & Anndrea Hermann from HGrown Consulting - a hemp consultancy focused on Mexico. We explore what’s happening with hemp and the situation of medical cannabis in Mexico, alongside the adult-use scenarios, and how Mexico can play a part in the hemp ecosystem. The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the Global Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ About José Lugardo Espejel José Lugardo Espejel, MSc, BMS, Co-founder of HGrown Consulting, co-foundeer of HPS Latam, Founder of Grupo Sativa Health. He started his career as a researcher and consultant in the private healthcare sector and has gained experience as a conferencist and ambassador for the medical cannabis industry in Mexico and Latin America. José currently also advises multiple cannabis startups, researchers, healthcare and pharmaceutical organizations, as well as legislators. His first startup Grupo Sativa Health, developed Sativa Care, the first medical cannabis clinic in Mexico. About Anndrea Hermann Anndrea Hermann, M.Sc, B.GS , P.Ag., Director of Inside Sales HPS Food & Ingredients, Principal The Ridge International Cannabis Consulting, Founder HGrown Consulting Mexico, Owner Hemp Technologies Canada, Founder iHempRadio, Founding Instructor OSU WSE266 Course, Canada Hemp Licensee who has advised Industry for 21+ years. President Emeritus & board Hemp Industries Association and Vice President Emeritus Canadian Hemp Trade Alliance. In 2021, she co-founded the rural non-profit Gerhard E. Dekker Regenerative Education Center. She was the first woman inducted into the Hemp History Hall of Fame (2017), recipient of the HIA Lifetime Achievement Award (2018) and listed on Hemp History Week top 10 advocates (2019). Anndrea is recognized and revered as a true ambassador of the highest caliber. Presenting she is publishing “Everybody Loves Trallala” a children’s book about a little hempseeds journey. Connect with José on LinkedIn: https://www.linkedin.com/in/pepelugardo Connect with Anndrea on LinkedIn: https://www.linkedin.com/in/anndrea-hermann-89647b37 HGrown Consulting Website: https://hgrown.mx/ Follow José on Twitter: https://mobile.twitter.com/pepe_lugardo…
T
The Cannabis Conversation | Medical Cannabis | CBD | Hemp

1 EPISODE #177: Cannabis in the Czech Republic with Lukas Hurt, Publisher of Magazine Konopí and Cannabis Therapy Magazine 27:15
27:15
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب27:15
On the latest episode of The Cannabis Conversation, we’re joined by Lukas Hurt, Publisher of Magazine Konopí and Cannabis Therapy Magazine. We explore what’s currently happening in the Czech Republic and the current status of medical cannabis and CBD, as well as recreational legalisation plans, and the Czech Republic and Germany’s future collaboration in furthering these aims. The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ About Lukas Hurt Lukas Hurt is a Czech editor, translator, journalist, and publisher. For more than ten years, he has been using his education and skills in the field of translatology to bring as much information as possible about medical properties and benefits of cannabis to the general public and he is actively participating in the whole legalization movement on national as well as international level. Throughout the years, Lukas has become involved in organizing several medical conferences, exhibitions as well as the biggest cannabis fair in the world - Prague's Cannafest. Since 2018 he is also the publisher and editor-in-chief of Czech bimonthly Konopí and the publisher of English online magazine Cannabis Therapy. Resources Connect with Lukas on LinkedIn: https://www.linkedin.com/in/lukas-hurt-a9565815 Magazine website: https://magazin-konopi.cz/ and English: https://cannathemag.com/ Follow Lukas on Facebook: https://www.facebook.com/lukas.hurysek/…
T
The Cannabis Conversation | Medical Cannabis | CBD | Hemp

1 EPISODE #176: Hemp - Environmental Saviour? with Mike Morgan-Giles & Jamie Bartley 37:10
37:10
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب37:10
On the latest episode of The Cannabis Conversation, we speak with Mike Morgan-Giles from the Cannabis Industry Council and Jamie Bartley from the Unyte Group. Together, we explore some of the environmental credentials of hemp, and which sectors hemp can play a sustainable role in, alongside exploring the challenges that exist around its wider adoption, and some of the practical changes needed to promote this. The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ About Mike Morgan-Giles Mike Morgan-Giles is the CEO of the Cannabis Industry Council. He is an experienced membership and third sector leader, having worked in various senior communications, public affairs, and marketing roles in two countries. About Jamie Bartley Jamie Bartley is the CEO of the Unyte Group and sits on the executive of the Cannabis Industry Council, Chairing the Hemp subgroup. His main focus is scaling the impacts that Hemp and Medicinal Cannabis can have on improving human and planetary health. Resources Connect with Mike on LinkedIn: https://www.linkedin.com/in/mikemg Cannabis Industry Council’s Website: https://lnk.bio/ukcancouncil Follow Mike on Twitter: https://twitter.com/mikemgiles Connect with Jamie on LinkedIn: https://www.linkedin.com/in/jamie-bartley-67ba4a1a Unyte Group’s Website: https://unyte.co.uk/…
T
The Cannabis Conversation | Medical Cannabis | CBD | Hemp

1 EPISODE #175: How important are THC:CBD ratios? with Guillermo Moreno-Sanz, PhD, Global Scientific Director of Khiron Life Sciences Corp 57:27
57:27
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب57:27
How important are THC:CBD ratios? On the latest episode of The Cannabis Conversation, we’re joined by Guillermo Moreno-Sanz, PhD of Khiron Life Sciences Corp - a global provider of cannabis-based medicines and healthcare services. We explore how THC and CBD work on the body individually, our current understanding on how they interact together, and discuss the recent findings of the King's College study on THC and CBD interaction. The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ About Guillermo Moreno-Sanz, PhD Guillermo Moreno-Sanz, PhD has been dedicated to cannabinoid research for almost 20 years and has authored more than 30 scientific articles and 3 patents describing the role of the endocannabinoid system in pain perception. He received his degree in Biochemistry and Organic Chemistry from the University of Zaragoza, and his PhD in Neurosciences from the Complutense University of Madrid, Spain. He gained extensive international experience with long-term fellowships at the University of Leiden in the Netherlands and at the Department of Drug Discovery and Development at the Italian Institute of Technology in Genoa, Italy. Dr. Moreno-Sanz was awarded a Fulbright Scholarship to complete his Ph.D. in the United States, spending most of his academic career at the University of California, Irvine. There he discovered and characterized a new class of cannabinoid analgesics that are currently in clinical development. In 2017, Dr. Moreno-Sanz served as a consultant to the U.S. National Academies of Sciences in the development of the report "The Health Effects of Cannabis and Cannabinoids" and founded his own consulting firm, Abagune Research, to provide scientific advice and R&D solutions to leading companies in the cannabis industry internationally. In 2020, he joined Khiron Life Sciences Corp as scientific and medical director for Europe and, in 2021 he became the scientific director of the company. Khiron Life Sciences is a global provider of cannabis-based medicines and healthcare services through its network of Zerenia™ clinics, with a presence in Colombia, Peru, Brazil, UK, and Germany. Resources Connect with Guillermo Moreno-Sanz, PhD on LinkedIn: https://www.linkedin.com/in/guillermomorenosanz Khiron Med’s Website: https://khironmed.co.uk/…
T
The Cannabis Conversation | Medical Cannabis | CBD | Hemp

1 EPISODE #174: Cannabis Genetics and Breeding with Dr Gavin George, Co-founder of Puregene AG 42:46
42:46
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب42:46
How can we get the most out of the cannabis plant? On the latest episode of The Cannabis Conversation, we speak with Dr Gavin George, CEO of Puregene AG - a Swiss company specialising in genomics and predictive plant breeding. We explore the potential of cannabis to produce hundreds of different products, including the challenges that come with it. We also explore the process of plant breeding, how much scope the cannabis plant has to evolve, and some of the new technologies needed to maximise this potential. The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ About Dr Gavin George Dr. Gavin George is a Cofounder of Puregene AG and previously held the position of Director of Research and Intellectual Property, before being appointed to CEO. Dr. George was awarded a PhD in Plant Biotechnology in 2010 from the Institute for Plant Biotechnology at the University of Stellenbosch, South Africa. He subsequently worked for 7 years at the ETH Zurich as a Postdoctoral Researcher where he investigated the relationship between internal and external factors on plant growth. He has authored 14 peer reviewed publications and contributed to 3 books. His research was focused on the improvement of various crop species including sugarcane, tobacco, tomato, and potato as well as the creation of research devices for the detailed measurement of phenotypic traits. As the Director of Research and IP at Puregene, he ensured that the high-throughput analytical, phenotyping, biochemistry and sequencing technology platforms optimally support the breeding activities and global intellectual property pipelines of Puregene. As CEO he is focused on working with more international commercial partners and academic institutes for the development of new markets for cannabis and hemp genetics and the deployment of complete breeding programs. Resources Connect with Dr Gavin George on LinkedIn: https://www.linkedin.com/company/puregene-ag/ Puregene AG’s Website: www.puregene.com Follow Dr Gavin on Instagram: @puregeneag Follow Dr Gavin on Twitter: @puregene…
T
The Cannabis Conversation | Medical Cannabis | CBD | Hemp

1 EPISODE #173: What's Wrong With The Cannabis Industry? with Dr. Ethan Russo, Founder of Credo Science 44:07
44:07
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب44:07
What’s wrong with the cannabis industry? Joining us again on the latest episode of The Cannabis Conversation is Dr Ethan Russo, Founder of Credo Science - a novel medical science company. We discuss the prejudice and ignorance against Cannabis, as well as safety monitoring, legalisation and some of the challenges the industry is facing, including a lack of proper funded research in the area. The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ About Ethan Russo Ethan Russo, MD, is a board-certified neurologist, psychopharmacology researcher, and Founder/CEO of CReDO Science https://credo-science.com He is also Medical Director of Andira Pharmaceuticals Andira – Bringing Healing to Life and Senior Medical Advisor to Canurta Home | Canurta Previously he was Director of Research and Development for the International Cannabis and Cannabinoids Institute, 2017-19, Medical Director of PHYTECS, 2015-2017, and from 2003-2014, Senior Medical Advisor, medical monitor/study physician to GW Pharmaceuticals for numerous Phase I-III clinical trials of Sativex® and Epidiolex®. He was a clinical neurologist in Missoula, Montana for 20 years. He has held faculty appointments in Pharmaceutical Sciences at the University of Montana, and in Medicine at the University of Washington. He is author/editor of seven books and has published more than 50 peer-reviewed articles. Resources Join Dr. Russo on LinkedIn: https://www.linkedin.com/in/ethan-russo-md-468b19a/ View Dr. Russo’s clinical research papers: https://www.researchgate.net/profile/Ethan_Russo CReDO Science Website: https://credo-science.com/…
T
The Cannabis Conversation | Medical Cannabis | CBD | Hemp

1 EPISODE #172: Medical Cannabis Patients with Mags Houston, Matt Hughes, Hannah Deacon, & Mary Biles 32:01
32:01
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب32:01
In this week’s episode, we’re joined by Mags Houston from Drug Science, Mary Biles (author of The CBD Book), Matt Hughes from MedCan Support, and Hannah Deacon from The Medical Cannabis Clinicians Society to discuss the upcoming UK Patient Conference on 4th Nov in London. We discuss the importance of patient conferences to patients themselves, parents, and anyone interested in learning more about cannabis-based medicines. The upcoming conference will feature talks from some of the leading experts in the field, as well as opportunities to learn about patient experiences, the latest research, and developments. Whether you're new to the topic or have been following the medical cannabis debate for some time, this is a great opportunity to get involved and learn more. This promises to be a fascinating and informative event, so if you are a patient or interested in medical cannabis then make sure you register for free today for the livestream - unfortunately in-person tickets are all sold out! Date and time: Fri, 4 Nov 2022, 10:30 – 18:30 GMT Tickets are available through this link: UK Patience Conference The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ About Our Guests Mags Houston As Head of Projects & Comms for Drug Science , Mags oversees the running of Drug Science’s medical cannabis observational study, Project Twenty21. The study helps to raise awareness of medical cannabis, building more evidence by attracting more patients and prescribers to actively join the project, and educating the public about the growing evidence surrounding medical cannabis for treating a range of conditions. Matt Hughes Having campaigned for NHS access to prescription his son Charlie since 2019 and the knowledge he gained through experience, In collaboration with Hannah Deacon, Matt formed MedCan Support, having felt there was a gap in education for parents, carers and families. Building a central forum to educate and inform parents and carers so they can work with their doctors to make informed decisions on their loved ones care. To provide a safe space for parents and carers to ask questions about prescription cannabis and feel confident to advocate for their child or family members health care needs. Hannah Deacon Medical cannabis expert & campaigner Hannah Deacon is one of the most influential and high-profile female leaders in the UK's medical cannabis sector.With an international reputation for pioneering change, as a dedicated patient advocate, Hannah also works to overcome barriers to medical cannabis treatment in the UK, supporting better education for doctors so patients across the country get the access they need. Mary Biles Mary Biles is the author of The CBD Book, a regular contributor to Project CBD and host of the podcast Cannabis Voices . She is a vocal advocate of greater access to medicinal cannabis for patients and fostering an industry where patients' needs are firmly held at the centre of companies' business models.…
T
The Cannabis Conversation | Medical Cannabis | CBD | Hemp

1 EPISODE #171 Holistic Health and Cannabis with Dr Dani Gordon, Founder and Medical Director of Resilience.Clinic 33:12
33:12
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب33:12
This week we’re joined by Dr Dani Gordon, Founder and Medical Director of Resilience.Clinic - specialising in the treatment of complex multi-symptom conditions which affect mood, energy, mental function (brain fog), stress, pain, sleep, and digestion. Together, we explore some of the conditions medical cannabis can help with, the non-medical interventions that form part of a holistic health regime, and how medical cannabis can play a part in that. The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ About Dr Dani Gordon Dr Dani Gordon MD is a double board certified integrative medicine physician and leading expert in integrative and cannabinoid medicine, and resilience. She has treated thousands of patients with medical cannabis, is vice chair of the UK Medical Cannabis Clinicians Society and is author of ‘The CBD Bible.’ She is the founder and Medical Director of Resilience.Clinic, her UK medical practice and wellbeing platform with a focus on mental health, chronic fatigue and complex chronic disease. She is regularly interviewed for TV and the media and has been featured in the Sunday Times, The Guardian, BBC, Vogue and Marie Claire. Resources Connect with Dr Dani Gordon on LinkedIn: https://www.linkedin.com/in/drdanigordon/ Follow Dr Dani on Twitter: https://twitter.com/drdanigordon Follow Dr Dani on Instagram: https://www.instagram.com/drdanigordon/ Subscribe Dr Dani on Youtube: https://www.youtube.com/user/DrDaniMD Resilience Medicine Clinics’ website: https://resiliencemedicine.clinic/…
T
The Cannabis Conversation | Medical Cannabis | CBD | Hemp

1 EPISODE #170 Cannabis Conferences and Events with Ben Arn, CEO of Cannatrade and CB Company 29:29
29:29
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب29:29
Joining us on the latest episode of The Cannabis Conversation is Ben Arn, CEO of Cannatrade and CB Company - cannabis events companies based in Switzerland. Ben gives us a round-up of the latest Swiss cannabis industry news, and we also discuss the crucial role that events and conferences play, not only in driving the cannabis industry forwards, but expanding education and reducing stigma. 📚 VIEW SHOW NOTES AND EXTRAS: www.canverse.global/shownotes/e170 The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ About Ben Arn Ben has been the organizer of Cannabis Events in Switzerland since 2006. His projects also include CannaTrade - International Cannabis Expo (b2c and b2b) in Bern, the CB Expo - Cannabis Business Expo (b2b) and the CB Club - Cannabis Business Network event in Zurich. In 2022 he is also organising the Cannabinoid Conference 2022 (12th IACM Conference and 1 st SSCm Confernce) in Basel. His passions are organising events and connecting people, and the enormous potential of the cannabis plant. Timestamps 0:00 Welcome to The Cannabis Conversation 0:58 Introduction to Ben and how he got into the cannabis industry 2:40 How Ben became involved in Cannatrade 3:59 Switzerland’s new medical cannabis laws and pilot projects 4:27 An overview of the current state of play in Switzerland regarding cannabis products 7:12 Recreational cannabis trials in Switzerland in 2022 9:50 About Cannatrade, CB Expo and CB Club 14:25 How important are events and conferences for an emerging industry like cannabis? 17:39 What are the differences between big events and smaller intimate ones? 22:00 Do you have any networking tips or tricks? 24:11 How important it is to get people from outside the industry coming to conferences to learn more about what's happening? Resources Follow CannaTrade on LinkedIn: https://www.linkedin.com/company/cannatrade/ Follow CB Company on LinkedIn: https://www.linkedin.com/company/71937276/ Follow Cannabis Medicinalis on LinkedIn: https://www.linkedin.com/company/cannabis-medicinalis…
T
The Cannabis Conversation | Medical Cannabis | CBD | Hemp

1 EPISODE #169 Clinical and Pre-Clinical Cannabinoid Research with Dr. Mikael Sodergren, Managing Director at Sapphire Medical Clinics 39:12
39:12
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب39:12
In our latest episode, we welcome Dr. Mikael Sodergren, Medical Cannabis Research Group Lead at Imperial College London and Managing Director at Sapphire Medical Clinics. We examine how clinical trials and real-world evidence can be used to prove the efficacy of cannabis-based medicines, as well as the challenges associated with applying traditional licensing and regulatory models to these novel medicines. 📚 VIEW SHOW NOTES AND EXTRAS: www.canverse.global/shownotes/e169 The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ About Mikael Sodergren Dr Mikael Sodergren MBChB(Hons) DIC PhD FRCS, is a Clinical Senior Lecturer at Imperial College London where he leads the Medical Cannabis Research Group. He is co-founder of Sapphire Medical Clinics, the first medical cannabis clinic approved by the CQC in England, and Chief Medical Officer at Curaleaf International. Timestamps 0:00 Welcome to The Cannabis Conversation 1:08 Introduction to Dr. Mikael Sodergren and his clinical work as a surgeon within oncology 3:48 Dr. Sodergren’s initial research into the use of CBD in cancer treatment and interest in medical cannabis 5:43 Dr. Sodergren’s current research into pain pathways and the use of cannabis to combat acute and chronic pain 7:57 Imperial College London and its progressive research within cannabis (and psychadelics) 09:35 Have you ever encountered any stigma from peers or colleagues? 11:02 The founding of Sapphire Medical Clinics 13:30 How does the process of clinical research work? 18:12 How are regulators involved in the process? 19:04 Preclinical research and what is involved 20:21 What challenges are involved with cannabis drug development? 26:33 Randomised controlled trials and their use within medical cannabis development 29:59 Clinical trials vs. real world evidence 31:48 How do you feel about the use of cannabis flower as a medicine? 33:33 What factors can help accelerate medical cannabis research? Resources Sapphire Medical Clinics’ Website: https://www.sapphireclinics.com/ Follow Sapphire Medical Clinics on LinkedIn: https://www.linkedin.com/company/sapphire-medical-clinics/ More about the Medical Cannabis Research Group at Imperial College London:…
T
The Cannabis Conversation | Medical Cannabis | CBD | Hemp

1 EPISODE #168 Cannabis and Traumatic Stress with Gary Roberts, Cannabis Entrepreneur and Host of Good Dudes Grow Podcast 39:23
39:23
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب39:23
This week, we welcome Gary Roberts, firefighter, CEO of Promises Recovery, Inc. and Host of Good Dudes Grow Podcast. We examine PTSD and traumatic stress, along with the evidence of how cannabis can help in a therapeutic way. Gary also shares his personal journey through grief, which ultimately led him to found a non profit recovery centre for those in need. 📚 VIEW SHOW NOTES AND EXTRAS: www.canverse.global/shownotes/e168 The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ About Gary Roberts 18-year active duty firefighter. Gary also has over 30 years of experience in the fitness industry, focusing on athlete coaching, physical recovery programs, and mental training for athletic performance. Given his background and ability to learn and overcome psychological and physical trauma, medical training, and understanding how the body can be adaptive to proper prevention and post-recovery protocols. Gary has founded Promises Innovative Recovery to become a mental and physical health leader using innovative therapeutics like plant-based medicine and psychedelics. PIR focuses continuously on moving the needle forward with new and successful programs to benefit those in need. Timestamps 0:00 Welcome to The Cannabis Conversation 0:46 Gary’s personal background, work as a firefighter, and why he became involved in recovery 5:15 Gary’s entrepreneurial journey and starting his CBD brand Pure Body Zen 14:13 Gary’s motivations for starting his CBD brand, and the challenges faced using CBD as a firefighter 16:00 Introduction to traumatic stress, PTSD, and Gary’s experiences of this 19:38 Are there different types of PTSD? 22:21 How do first line responders and firefighters usually treat alcohol? 25:15 How can cannabis help with traumatic stress? 27:33 The balance of THC and CBD for therapeutic use 31:45 The use of MDMA for post traumatic stress Resources Connect with Gary on LinkedIn: https://www.linkedin.com/in/good-dudes-grow/ Follow Good Dudes Grow Podcast on Instagram: https://www.instagram.com/gooddudesgrowpodcast/ Follow Promises Innovative Recovery on LinkedIn: https://www.linkedin.com/company/promises-innovative-recovery/ Promises Recovery Centers’Website: www.promisesrecoverycenters.com Promises Innovative Recovery’s Website: www.promisesinnovativerecovery.com…
T
The Cannabis Conversation | Medical Cannabis | CBD | Hemp

1 EPISODE #167 Building A Cannabis Investment Thesis with Helene Servillon, Fund Manager at JourneyOne Ventures 44:01
44:01
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب44:01
This week, we’re joined by Helene Servillon, Founding Partner at JourneyOne Ventures - woman and minority owned early stage cannabis fund. We explore some of the current cannabis investment themes in the USA, core sectors of the market where innovation is desperately needed, and how to approach cannabis investments in an ecosystem which is so fragmented. 📚 VIEW SHOW NOTES AND EXTRAS: https://www.canverse.global/shownotes/e167 The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ About Helene Servillon Helene Servillon is the Founding Partner of JourneyOne Ventures, a 100% woman and minority owned early stage cannabis fund that invests in founders with prior executive-level management experience in cannabis or tangential industries. The JourneyOne team has 45 years of combined cannabis expertise and is focused on uncovering the biggest pain points in the industry. They are focused on investing in the most venture-scale sectors of the market which includes tech, tech-enabled services and companies with unique IP. She is also a Senior Advisor to Bowen's cannabis practice, a Boston based investment bank with a 20 year track record in capital raise advisory and buy-side and sell side M&A. Their cannabis practice covers tech, licensed operators, and ancillary services. Timestamps 0:00 Welcome to The Cannabis Conversation 02:58 Helene’s professional background 05:42 Did you encounter any stigma when you decided to get into cannabis? 7:19 About JourneyOne Ventures, what businesses and industry sectors they invest in 11:35 The biggest pain points in the cannabis market 12:49 Helene’s role leading the Cannabis team at at Bowen (growth-tech investment bank) 17:36 Being a female founder and a minority within the cannabis space 22:49 How to build a cannabis investment thesis 31:20 How important is your network when building an investment portfolio? 33:45 Are you looking to invest in other durastrictions beyond the US? 34:45 What are two disappointments and two upcoming opportunities within the cannabis market in Europe? Quotables “Relative to the overall category of venture capital, the cannabis industry's still living in ancient days, when it comes to diversity” Resources Connect with Helene on LinkedIn: https://www.linkedin.com/in/hservillon/ Follow JourneyOne Ventures on LinkedIn: https://www.linkedin.com/company/journeyone/ Follow JourneyOne Ventures on Twitter: https://twitter.com/JourneyOneVC JourneyOne Ventures’ Website: https://www.journeyone.vc/…
T
The Cannabis Conversation | Medical Cannabis | CBD | Hemp

1 EPISODE #166 CBD and Sexual Wellness with Dr. Dmitry Loktionov & Kate Tikhomirova from Quanna 23:03
23:03
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب23:03
This week we’re joined by Dr. Dmitry Loktionov & Kate Tikhomirova, co-founders of Quanna - premium self-care and sexual wellness brand powered by CBD. We explore the emergence of the sexual wellness sector and the role CBD can play within it. 📚 VIEW SHOW NOTES AND EXTRAS: https://www.canverse.global/shownotes/e166 The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ About Dr. Dmitry Loktionov, Co-Founder Quanna’s founder Dr. Dmitry Loktionov graduated from the Royal College of Surgeons in Ireland and the National University of Ireland in 2014. He was awarded an honours degree in MB, BCh, BAO, LRCP & SI. He later went on to train in Obstetrics and Gynecology in Ireland for 4 years, during which time he published multiple research papers in national and international medical journals. Dr. Loktionov has presented in multiple national and international conferences and won prestigious awards for his research presentations. Moving to London to pursue his interest in holistic and complementary medicines, he started researching the benefits of the Cannabis plant. Dr. Loktionov is keen on combining his knowledge of western conventional medical practices with eastern holistic approaches to diagnose and treat his patients. About Kate Tikhomirova, Co-Founder Quanna’s other founder Kate Tikhomirova established herself as a fashion and lifestyle influencer over the last 5 years and during her years living in Los Angeles has become accustomed to the world of CBD. Behind the scenes of fabulous posts overseas and rent-worthy outfits there is the realities of anxiety and insomnia. CBD not only helped Kate relieve her daily pressures, but it was held to the highest esteem when her mother became sick with advanced cancer that Kate really delved into the power of the plant. After seeing her mum in constant pain and agony, after numerous rigorous treatments, the best a caretaker can do is listen to any possibility that can make this better. Kate discovered that CBD helped her mum rest easier and managed her aches without the side effects of stronger sleeping drugs or pain medication. It was eye opening to say the least for it was not a gateway, but a shedding of light on the future for our bodies. Timestamps 0:00 Welcome to The Cannabis Conversation 00:50 Introduction to Kate and life as a social media influencer 01:57 Did you have any Issues around stigma attached to cannabis when you founded the brand? 03:18 Introduction to Dmitry and his career as a gynecologist 03:49 Quanna’s origins 04:29 Are doctors becoming more interested in cannabis? 05:16 About Quanna’s products and company goals 06:36 Brand challenges, meta censorship, and raising awareness of sexual wellness 09:45 What does sexual wellness involves? 10:45 The current and historical lubricant market 13:06 How CBD works within the products 14:06 Does CBD help with both pleasure and pain? 14:59 What other ingredients are used in your formulation? 17:52 How the product works 18:45 The role of THC in sexual wellness Resources Connect with Dr. Dmitry on LinkedIn:…
T
The Cannabis Conversation | Medical Cannabis | CBD | Hemp

1 EPISODE #165 The European Cannabis Jobs Market with Nikita Cretu & Ellen Jardim from Lumino 33:48
33:48
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب33:48
In this episode of The Cannabis Conversation, we’re joined by Nikita Cretu & Ellen Jardim, from our lovely sponsors Lumino - Europe's leading cannabis recruitment agency. Together we explore the European cannabis jobs market, looking into its structure and sub sectors, the most in-demand jobs and skills, and advice for talent looking to enter the market. 📚 VIEW SHOW NOTES AND EXTRAS: www.canverse.global/shownotes/e165 The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ About Nikita, Co-Founder and COO Nikita Cretu is a Co-founder and COO of Lumino, a recruitment consultancy focused on exclusively aligning talent within the emerging European Cannabis Industry. In 2015, during and more extensively after his business degree, Nikita started working for Europe's first cannabis clinic in Spain, where he was responsible for the expansion into the German market and developed a deeper understanding and passion for the needs and effectiveness of cannabis based medicines and how they greatly improved the quality of patients lives. This passion drove Nikita to project manage and in turn consult various cannabis companies in the Americas, Germany, Switzerland, Spain and the UK in the field of licensing, real estate, raw materials and genetics before the inception of Lumino. With Nikita’s passion for drug policy reform, patient access and overall love for the industry and its potential, he can not wait to further develop this space by supporting value driven organisations and professionals who’s culture, expertise and knowledge can shape this industry for the better. About Ellen, Managing Director Ellen Jardim is the Managing Director for Lumino Group with a background in traditional pharmaceutical recruitment. She is the architect and operator of the entire recruitment process which is specifically designed to match the nuanced requirements of the emerging cannabis industry. Building strong, long term and mutually beneficial relationships with clients and candidates. She thrives when working in diverse companies that are driven by strong values and ethics. Timestamps • 0:00 Welcome to The Cannabis Conversation • 01:21 Introduction to Ellen and her background • 02:09 Did you face any issues with the topic area or from friends and family when starting to work in the cannabis industry? • 03:09 Being a Christian in cannabis • 03:47 Introduction to Nikita and his background • 09:20 About Lumino and the three verticals they operate in • 12:04 Lumino’s bespoke approach • 13:33 How Covid affected the cannabis jobs market • 16:37 Sectors and subsectors within the cannabis jobs market • 18:03 Popular jobs in the European cannabis industry right now • 23:33 Existing industries job seekers are coming from • 27:33 Advice for people looking to get into the cannabis industry Resources Connect with Ellen on LinkedIn: https://www.linkedin.com/in/ellen-jardim-407458145/ Connect with Nikita on LinkedIn: https://www.linkedin.com/in/nikita-cretu-b24b83a8/ Follow Lumino on Li…
T
The Cannabis Conversation | Medical Cannabis | CBD | Hemp

1 EPISODE #162 Cannabis Stands With Ukraine, with Maksym Kharkavyi, Nazarii Sovsun, and Bogdan Yetsenko from Freedom March 29:24
29:24
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب29:24
We’re joined by Maksym, Nazarii, and Bohdan from Freedom March, who are the organisers of the Cannabis Stands with Ukraine fundraising campaign - aiming to unite the world’s cannabis community to support Ukrainians. We explore the current state of cannabis access in Ukraine, and what the campaign is doing in order to provide critical humanitarian assistance to the people in need. Donate now at https://cannabiswithukraine.org/ 📚 VIEW SHOW NOTES AND EXTRAS: https://www.canverse.global/shownotes/e162 About Freedom March Freedom March, Ukrainian cannabis law reform civil movement, advocates legal access to medical cannabis, its decriminalization and the public monitoring of law enforcement since 2005. The movement also defends in court those accused of possession of marijuana based products for personal use. Freedom March cooperates with such organizations as Veterans for Medical Cannabis, Athena. Women against Cancer, People with Epi, as well as individual scientists, medics, artists, and nightclubs around the world. The legal entity of Freedom March is NGO МІСТ. Resources Cannabis Stands With Ukraine Article in High Times: https://hightimes.com/news/ukrainian-cannabis-community-standing-strong-against-russian-invasion/ The Kyiv School of Economics Fund: https://kse.ua/ Cannabis Stands With Ukraine Campaign Website: https://cannabiswithukraine.org/ Cannabis Stands With Ukraine Instagram: https://www.instagram.com/cannabiswithukraine/…
T
The Cannabis Conversation | Medical Cannabis | CBD | Hemp

1 EPISODE #164 The Evolving CBD Market with Phillip Glyn, Founder and Director at Vitality CBD 29:25
29:25
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب29:25
On the latest episode of The Cannabis Conversation, we’re joined by Phillip Glyn, Founder and Director at Vitality CBD - one of the UK’s leading CBD brands. Together, we reflect on the state of the CBD market in the UK, the impact of the FSA’s Novel Foods Regulations on the sale of CBD, as well as discussing the future of CBD retailing in the UK. 📚 VIEW SHOW NOTES AND EXTRAS: https://www.canverse.global/shownotes/e164 About Phillip Glyn Phillip has been a serial entrepreneur for the past 20 years and is the Founder and Director of Vitality CBD, UK’s leading CBD brand with a focus on creating trustworthy, all-natural products. With unrivalled marketing support, Vitality CBD has established itself as a leader in a rapidly expanding marketplace. Distribution has grown to 4000+ stores including some of the UKs large retailers, such as Boots, Tesco, ASDA plus Amazon and Ebay invitation only pilot scheme, in addition to 1000s of independents. The company was acquired in August 2021 by a Canadian public company, Yooma Wellness Inc. Quotables ‘We took it upon ourselves to build a category. We weren't just putting a product on a shelf and hoping it sold. What we were trying to do is lead by example’ Resources Connect with Phillip on LinkedIn: https://www.linkedin.com/in/phillip-glyn-18435333/ Vitality CBD’s Website: https://vitalitycbd.co.uk/ Follow Vitality CBD on Instagram: https://www.instagram.com/vitalitycbduk/…
T
The Cannabis Conversation | Medical Cannabis | CBD | Hemp

1 EPISODE #163 Cannabis Mythbusting with Dr. Callie Seaman Research Director and Formulation Chemist at AquaLabs 32:11
32:11
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب32:11
On the latest episode of The Cannabis Conversation, we’re joined by Dr. Callie Seaman, Research Director and Formulation Chemist at AquaLabs - nutrient solution provider to the hobby and medical horticultural market, and UK licensed medical cannabis cultivation research facility. We investigate some of the biggest cannabis myths, including why cannabis should not be seen as a cure, why THC should not be demonised, and why we need to be more realistic about what cannabis can achieve. 📚 VIEW SHOW NOTES AND EXTRAS: https://www.canverse.global/shownotes/e163 About Dr. Callie Seaman Dr. Callie Seaman (MRSC, SCImem) is a Cannabis Scientist with a PhD in hydroponic fertilizer biochemistry, and a passion for pharmacology. Callie Seaman describes herself as an epilepsy warrior, first being diagnosed at the age of 15, she went on to help form MedCan support and work closely with licenced cultivators in the UK and internationally. She also sits on the executive board of the Cannabis industry council, chairing the Adult use scoping group. Quotables I still experience stigma, but I think I just respond differently to it now. I stand proud, shoulders back, head up. I will not be ashamed of this plant or not be ashamed of what I do, and I will not be ashamed of what I fight for. Resources Connect with Callie on LinkedIn: https://www.linkedin.com/in/dr-callieseaman/ Follow AquaLabs on LinkedIn: https://www.linkedin.com/company/aqualabs-ltd/ Visit AquaLabs Website: https://aqualabs-uk.com/…
T
The Cannabis Conversation | Medical Cannabis | CBD | Hemp

1 EPISODE #161 Cannabis Vs. Opioids with Valentino Parravicini, Chief Scientific Officer at Oxford Cannabinoid Technologies 43:00
43:00
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب43:00
This week, we’re joined by Valentino Parravicini, Chief Scientific Officer at Oxford Cannabinoid Technologies - British pharmaceutical company developing a portfolio of next-generation prescription cannabinoid medicines. In this episode, we explore the potential use of cannabis-based medicines as a replacement for prescription opioids, their safety profile, and their use cases as analgesics. 📚 VIEW SHOW NOTES AND EXTRAS: https://www.canverse.global/shownotes/e161 About Valentino Parravicini Valentino has spent his academic career at the NIH (NIAMS-USA) working in allergy and inflammation and discovering a new signalling pathway in mast cells. After moving to the National Institute for Medical Research, Mill Hill (NIMR, now part of the Francis Crick), he focussed on animal models of inflammation and autoimmunity. He has been Visiting Scientist at Imperial College London and King’s College London. Valentino has over 12 years of experience in drug discovery and development accrued working in Big Pharma and SMEs. He worked at Roche (Italy), and at the Epigenetic Drug Performance Unit of the Immune-Inflammation Therapeutic Area of GlaxoSmithKline (GSK, UK). He was also involved in the set-up of two start-up biotechnology companies, first at Kesios Therapeutics (oncology), and the at GammaDelta Therapeutics (cell and gene therapy in oncology), which was recently acquired by Takeda. He has lead research teams and programmes in the fields of immune-inflammation, oncology, and virology, both in small molecules and cell therapy, applied to early research and drug discovery and development. He most recently joined Oxford Cannabinoid Technologies as Chief Scientific Officer where he contributed to shaping the cannabinoid-based R&D pipeline and overall scientific strategy leading to the Company’s IPO in May 2021. Resources Join Valentino on Linkedin: https://www.linkedin.com/in/valentino-parravicini/?originalSubdomain=uk Follow Oxford Cannabinoid Technologies on Linkedin: https://www.linkedin.com/company/oxford-cannabinoid-technologies/ Oxford Cannabinoid Technologies Website: https://www.oxcantech.com/…
T
The Cannabis Conversation | Medical Cannabis | CBD | Hemp

1 EPISODE #160 Cannabis Industry Crowdfunding with Andrew Sears, Business Development Associate at Seedrs 22:41
22:41
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب22:41
In this episode, we’re joined by Andrew Sears, Business Development Associate at Seedrs - Europe’s biggest crowdfunding platform. We explore how equity crowdfunding fits into the wider cannabis investment landscape in the UK, and what Seedrs is doing to help UK cannabis startups grow. 📚 VIEW SHOW NOTES AND EXTRAS: https://www.canverse.global/shownotes/e160 About Andrew Sears Andrew is originally from Sydney, Australia. Once completing a Bachelor of Arts and Master of Management at The University of Sydney, he distributed medical device instrumentation and implants as a territory manager for a large US HQ'd company, Orthofix. During the Master degree, Andrew worked for Deloitte Ventures which sparked his interest in the start-up ecosystem. Half English, it seemed a natural fit to move to London, United Kingdom to pursue his interest in early stage company investment. Since moving he's worked as an investment portfolio manager for a foreign direct investment company, investor relations for a B2B focused investment network and now, Seedrs, working with all of the exciting start-ups seeking to top-up their fundraising rounds with the largest equity crowdfunding platform in Europe. His sectors of interest are in CBD, Proptech, Insurtech and Mobility. He can't wait to continue to help start-ups with Republic's incoming acquisition of Seedrs to become the largest Private Investment Platform in the world. Resources Connect with Andrew on LinkedIn: https://www.linkedin.com/in/andrewsears Seedrs Website: http://www.seedrs.com Seedrs Twitter: http://twitter.com/seedrs…
T
The Cannabis Conversation | Medical Cannabis | CBD | Hemp

1 EPISODE #159 Cannabis and Ayurvedic Medicine with Abhishek Mohan, CEO of HempStreet 32:49
32:49
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب32:49
This week, we’re joined by Abhishek Mohan, Founder and CEO of Hempstreet - India's first research to retail venture in the Ayurvedic cannabis sector. We explore attitudes towards the medical use of cannabis within India, and how it currently fits into the framework of traditional Indian Ayurvedic medicine. 📚 VIEW SHOW NOTES AND EXTRAS: https://www.canverse.global/shownotes/e159 About Abhishek Mohan Abhishek is the Founder & CEO of HempStreet, which is India’s first and largest research to retail venture in the medical cannabis space. The company is now in the midst of India’s largest rollout of medicinal cannabis dispensing clinics and its network currently stands at over 9100 clinics accross 25 states. Hempstreet has also recently won the coveted BIG grant from BIRAC (the first ever medical cannabis company to win) for the development of a “world first” novel transdermal delivery technology for cannabinoids. Previous winners were biotech stakwarts like Bharat Biotech who developed one of the key covid-19 vaccines. Hempstreet is taking the fight to mass ailments utilising responsibly dispensed cannabis based medication. About HempStreet HempStreet is pioneering the future of medical cannabis research in the country by rejuvenating classical ayurvedic formulations through innovation and ground-breaking research. Quotables We're seeing a very, very big place globally for holistic medicine and cannabis is no exception Resources Connect with Abishek on Linkedin: https://www.linkedin.com/in/mohanabhishek/ HempStreet’s Website: https://www.hempstreet.in/ Follow HempStreet on LinkedIn: https://www.linkedin.com/company/hempstreetindia/?originalSubdomain=in…
T
The Cannabis Conversation | Medical Cannabis | CBD | Hemp

1 EPISODE #157 Cannabis and Traumatic Brain Injury with Nikki Lawley, Founder of Nikki and The Plant 30:36
30:36
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب30:36
This week, we’re joined by Nikki Lawley - cannabis advocate, educator, and Founder of Nikki and The Plant. Nikki shares her personal story of discovering and using medical cannabis to aid her recovery from a traumatic brain injury, along with her current patient advocacy work. 📚 VIEW SHOW NOTES AND EXTRAS: https://www.canverse.global/shownotes/e157 About Nikki Lawley, Founder of Nikki and The Plant Nikki Lawley is a patient advocate, speaker, and founder of Nikki and the Plant. She personally discovered cannabis as medicine after suffering a life-changing injury while working as a pediatric nurse. In October of 2016, Nikki was a 46-year-old woman whose life changed in literally a second. Going from being a medical professional to becoming a patient was a major adjustment and almost cost this vibrant mother, wife, and career professional to contemplating taking her own life after becoming a victim of the traditional medical system, seeing over 50 doctors, and was on cocktails of drugs that each had more and more side effects. Four months after her injury, Nikki found plant medicine. Nikki and the Plant is a pillar of medical cannabis advocacy and a champion for the importance of sharing patient stories. She is planning on creating the first product line focusing on cannabis and the science behind why cannabis helps support for her chronic pain, cognitive function, anxiety, and depression. Nikki is on the Patient Advisory Board for NY State Americans for Safe Access and for Cannabis BPO. Nikki is considered a leading voice in the community, chronicling her journey from being a healthcare provider to a patient to an advocate. She hopes to bring worldwide awareness to invisible illness and disability. She has been a guest on multiple podcasts and shows including “Let’s Be Blunt with Montel Williams. Quotables ‘When I find the right [cannabis], I'm a different human, I don't feel brain-injured’ Resources Nikki’s Website www.nikkiandtheplant.org Connect with Nikki on Linkedin: https://www.linkedin.com/in/nikki-lawley-aa281517/?trk=people-guest_people_search-card Nikki’s Facebook Page https://www.facebook.com/nikkiandtheplant Nikki’s Instagram: https://www.instagram.com/nikkiandtheplant/ Nikki’s YouTube: https://www.youtube.com/channel/UC8gIjFp_5cCEiwbTHBQXfrw…
T
The Cannabis Conversation | Medical Cannabis | CBD | Hemp

1 EPISODE #158 Psychedelics: The Investment Case with Jaspreet Grewal, Mitchell Osak, & Steve Hajioff 1:02:38
1:02:38
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب1:02:38
This week, we’re joined by Jaspreet Grewal, Mitchell Osak, & Steve Hajioff - three subject matter specialists within the psychedelics space. In this special panel episode, we explore the emergence (and re-emergence) of therapeutic psychedelics, including examining the substances which have gained early traction, the investment case for them, and the challenges and opportunities of this new sector. 📚 VIEW SHOW NOTES AND EXTRAS: https://www.canverse.global/shownotes/e158 Quotables [Psilocybin] can't be viewed as a miracle drug for everybody. I think that's really what it comes down to. We have to be very pragmatic that it's still an investigational compound. - Jaspreet Resources Connect with Steve on Linkedin: https://www.linkedin.com/in/stevehajioff/?originalSubdomain=uk Connect with Jaspreet on Linkedin: https://www.linkedin.com/in/jkgrewal/ Connect with Mitchell on Linkedin: https://www.linkedin.com/in/mitchellosak/…
T
The Cannabis Conversation | Medical Cannabis | CBD | Hemp

1 EPISODE #156 Drug Policy Reform in the UK with Katya Kowalski and Paul North from Volteface 35:15
35:15
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب35:15
This week, we’re joined by Katya Kowalski and Paul North from Volteface - the UK’s leading drug policy think tank. We explore London’s proposed drug diversion pilot scheme, along with the best practices for bringing about progressive drug policy reform in the UK. 📚 VIEW SHOW NOTES AND EXTRAS: https://www.canverse.global/shownotes/e156 About Katya Kowalski - Head of Operations Katya Kowalski is Head of Operations at Volteface, the UK’s leading drug policy think tank. She is responsible for overseeing project development, management and external engagement. Katya is an expert in global drug reform with a wealth of experience in research, and policy implementation. With a background in psychology she has a deep interest in the complex relationship between drug use and mental health. Katya enjoys commenting on the context and nuance surrounding drug use, along with the complexities and challenges of bringing cannabis into mainstream medicine. Since joining the Volteface team in 2020, Katya has launched the European Cannabis Advocacy Network (ECAN), a network of advocates across Europe to streamline communication across the continent about cannabis reform. Katya holds specific expertise in communications in drug reform and is passionate about advocating for sensible, practical drug policy models. Katya believes the key way to achieve meaningful change and de-stigmatising cannabis reform is by engaging hard to reach groups. Katya holds a BSc in Psychology and MSc in Health Psychology, both from the University of Bath. About Paul North - Director Paul has been with Volteface for over five years and is now the company's sole Director. His background is in criminology and drug treatment, a sector in which he held a variety of roles. It was Paul's first hand experience of witnessing the harms caused by the UK's drug policy which motivated him to enter the policy and lobbying space. Paul regularly comments in the media on drug policy and has written several reports which have been used to help create cross party political support for reform. Paul enjoys working with individuals and organisations to better engage with their key stakeholders and navigate the exceptionally complex relations between politicians, the media and society. Since joining Volteface in 2017 Paul has worked on national campaigns, delivered impactful policy reports, organised global study trips and produced documentaries. Alongside his current role at Volteface Paul lectures at several UK Universities on drug policy, addiction and morality. Quotables If you want sensible regulated reform… you have to find ways of engaging the industry Resources Join Katya on Linkedin: https://www.linkedin.com/in/katya-kowalski-38b530114/ Join Paul on Linkedin: https://www.linkedin.com/in/paul-north-3b6776151/ Voleface’s Website: https://volteface.me/…
T
The Cannabis Conversation | Medical Cannabis | CBD | Hemp

1 EPISODE #155 Cannabis Misinformation with Elana Goldberg, CEO of The Cannigma 30:27
30:27
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب30:27
In our latest episode, we’re joined by Elana Goldberg, CEO of The Cannigma - online cannabis content publication with a focus on scientific research and evidence. We dig into the topic of cannabis misinformation, including what The Cannigma are doing to combat it, why a science-based educational approach to cannabis education is best, and the real difference between sativa and indica. 📚 VIEW SHOW NOTES AND RESOURCES: https://www.canverse.global/shownotes/e155 About Elana Goldberg Elana is the CEO of The Cannigma. Born and raised in Sydney, Australia, she currently lives in Israel with her husband, two kids and neurotic dog. She has 15 years of experience developing online content products, including publications such as JPost.com, Goodnet.org, and Top10.com, and is passionate about delivering clear, compelling messages that anyone can understand. When she's not in front of the computer or pacing around on the phone, you can find her meditating, lifting weights, or camping with her family. Quotables “Personally, I think that pretty much, all cannabis is therapeutic in some way, whether the user knows it or not” Resources Connect with Elana on LinkedIn: https://www.linkedin.com/in/elanakirshgoldberg/ The Cannigma Website: https://cannigma.com/ The Cannigma on Facebook: https://www.facebook.com/thecannigma The Cannigma on Instagram: https://www.instagram.com/thecannigma/ The Cannigma on Twitter: https://twitter.com/thecannigma…
T
The Cannabis Conversation | Medical Cannabis | CBD | Hemp

1 EPISODE #154 The Rise of the US Craft Cannabis Industry with Max Simon, CEO & Co-Founder of Green Flower 40:05
40:05
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب40:05
This week, we welcome back Max Simon, CEO & Co-Founder of Green Flower - industry leading cannabis education platform empowering the next generation of cannabis professionals. We investigate the nuances that define 'craft' cannabis, how it is distinct from mass market flower, and why top quality cannabis products can be so hard to find in legal mass markets. 📚 VIEW SHOW NOTES AND EXTRAS: https://www.canverse.global/shownotes/e154 About Max Simon, Max Simon’s vision to change the world’s understanding of cannabis led him to create Green Flower, a first-of- its-kind education company, in 2014. Green Flower has since become the recognised industry leader in cannabis education and training, producing the world’s largest library of online cannabis courses; bolstering a network of more than 700 leading cannabis experts; powering the cannabis curriculums of multiple Universities across the US; successfully training cannabis workforces around the world; and creating the esteemed Ganjier Certification, known as the Cannabis Sommelier Certification. Max’s mission to educate the world about cannabis echoes his earlier work in bringing mind-body wellness and meditation into the mainstream as the Director of Consumer Products for world-renowned self-help guru Deepak Chopra. Max rebranded that company, developed and launched 49 signature products, and helped millions of people improve the quality of their lives along the way. Green Flower is also a deeply personal mission for Max, who has successfully used cannabis for more than two decades as an integral part of his wellness regime—and to aid in the treatment of his ADHD. Quotables ‘I have an unwavering certainty that not only cannabis can be used medicinally, but for many different conditions’ ‘If you want people to be successful, they need to have good education and training to play that role successfully’ Resources Green Flower’s Website: https://www.green-flower.com/ Green Flower’s Ganjier Programme: https://www.green-flower.com/certificates#ganjier Follow Green Flower on Linkedin: https://www.linkedin.com/school/greenflower/ Connect with Max on Linkedin: https://www.linkedin.com/in/max-simon-b51161156/…
T
The Cannabis Conversation | Medical Cannabis | CBD | Hemp

1 EPISODE #153 The UK Cannabis Investment Landscape with Oliver Lamb, Co-Founder of Óskare Capital 31:52
31:52
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب31:52
This week, we’re joined by Oliver Lamb - co-founder of Óskare Capital. Together, we examine the UK's cannabis startup investment landscape, including available funds, fundraising opportunities, and investor incentives. The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ 📚 VIEW SHOW NOTES AND EXTRAS: https://www.canverse.global/shownotes/e153 About Oliver Lamb Oliver Lamb started his career with an AIM listed investment firm focussed on Sub-Saharan Africa, before returning to London to join Morgan Stanley. Since then, Lamb set up a consultancy and accelerator in the Agri-Tech space through which he met, and subsequently joined forces with, the Óskare Capital team. Óskare has recently launched the MEDCAN fund, an SEIS and EIS fund targeting the medical cannabis sector that complements the wider European venture fund that the team is currently raising. Resources Óskare Capital’s Website: https://oskarecapital.com/medias/ Follow Óskare Capital on Linkedin: https://www.linkedin.com/company/oskare-capital/ Follow Oliver on Linkedin: https://www.linkedin.com/in/oliver-lamb-66580178/…
T
The Cannabis Conversation | Medical Cannabis | CBD | Hemp

1 EPISODE #152 The Impact of Cannabis on the Nicotine and Alcohol Markets with Spiros Malandrakis & Shane MacGuill from Euromonitor International 45:55
45:55
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب45:55
This week we’re joined by previous guests Spiros Malandrakis & Shane MacGuill from Euromonitor International - the world's leading independent provider of strategic market research. We examine the impact of the emergence of the cannabis industry on the legacy tobacco, nicotine, and alcohol markets, and how the sector may continue to disrupt these established global markets in the future. The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ 📚 VIEW SHOW NOTES AND EXTRAS: https://www.canverse.global/shownotes/e152 About Shane MacGuill - Global Lead, Nicotine and Cannabis Shane MacGuill conducts research and provides strategic analysis on all aspects of the global tobacco, nicotine and cannabis industries - working with a range of stakeholders to map the potential evolution and intersection of these industries. Collaborating with a broad spectrum of industry players including international manufacturers and companies in the supply chain, he leads conversations on consumer and industry trends and strategic development. A frequent contributor to the mainstream and business media including CNBC, Reuters, the Economist, Bloomberg, the Financial Times, the Sunday Times and the Times of London. About Spiros Malandrakis - Head of Research, Alcoholic Drinks and Cannabis Spiros Malandrakis has been providing pioneering insights on the evolution, branding and innovation within the global alcoholic drinks industry for the past decade. One of the first analysts to highlight the parallels, opportunities and pitfalls for the nascent cannabis market and its intersection with other FMCG industries. A key author in trade magazines and a frequent contributor to high profile business media such as Bloomberg, the BBC, the Financial Times, Reuters, the WSJ, Spiros is regular keynote speaker in some of the industry’s most sought after conferences, and a firm believer in irreverent, opinionated and independent analysis. Resources Euromonitor’s Website: https://www.euromonitor.com/ Connect with Spiros on LinkedIn: https://www.linkedin.com/in/spiros-malandrakis-36830446/ Connect with Shane on LinkedIn: https://www.linkedin.com/in/shanemacguill/…
T
The Cannabis Conversation | Medical Cannabis | CBD | Hemp

1 EPISODE #151 Cannabis Industry: Hype vs. Reality with Matt Lamers, International Editor at MJBiz 42:14
42:14
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب42:14
This week we’re joined by Matt Lamers, International Editor at MJBiz - the leading industry news and data source for cannabis. We investigate hype vs. reality within the cannabis industry as a whole, the impact of historical over-investment into large Canadian licensed producers, and some of the reasons why expectations of growth have not been met. The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ 📚 VIEW SHOW NOTES AND EXTRAS: https://www.canverse.global/shownotes/e151 About Matt Lamers Matt is based in the Greater Toronto Area and covers international cannabis markets for Marijuana Business Daily. Previously, he worked as a business editor, photographer and reporter for newspapers and magazines in three countries, covering everything from the oil and gas industry in northern British Columbia to North Korean defectors in Seoul. Quotables ‘In the cannabis industry, I think we need more journalists, traditional journalists or people asking hard questions’ Resources MJBiz’s Website: https://mjbizdaily.com/ Connect with Matt on Linkedin: https://www.linkedin.com/in/matthewhlamers/ Follow MJBiz on Linkedin: https://www.linkedin.com/company/mjbiz/…
T
The Cannabis Conversation | Medical Cannabis | CBD | Hemp

1 EPISODE #150 Cannabinoid Acids with Dr. Raphael Mechoulam, Professor of Medicinal Chemistry at The Hebrew University of Jerusalem 36:54
36:54
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب36:54
This week is a special episode - our 150th! And we’re honoured to be celebrating this milestone by welcoming back Dr. Raphael Mechoulam to the show - ‘The Godfather of Cannabis Research'. Together, we deep dive into Dr. Mechoulam's current work looking at cannabinoid acids - examining their role interacting with the endocannabinoid system, their manipulation into compounds, as well as discussing his latest research into endogenous cannabinoids. The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing. Get in touch at www.luminorecruit.com/ 📚 VIEW SHOW NOTES AND EXTRAS: https://www.canverse.global/shownotes/e150 About Dr. Raphael Mechoulam Dr. Raphael Mechoulam is an award-winning Israeli organic chemist who has been studying the cannabis plant for over 50 years. Dr. Mechoulam is best known for discovering the Endocannabinoid System and first isolating the two primary compounds, CBD and THC. He is a professor of Medicinal Chemistry at the Hebrew University of Jerusalem in Israel and has published over 350 scientific articles, primarily focused on the chemistry and pharmacology of Cannabinoids. His work has awarded him with many honors and awards, including the Israel Prize (2000), NIDA Discovery Award (2011) and many others. Quotables “I hope that people will look at cannabis research as a positive thing, and I hope that it brings us an additional understanding of what our body does” Resources Dr. Mechoulam’s Wikipedia Page: https://en.wikipedia.org/wiki/Raphael_Mechoulam Dr. Mechoulam’s papers on Google Scholar: https://scholar.google.co.uk/citations?user=err5l-YAAAAJ&hl=en The Multidisciplinary Center for Cannabinoid Research’s Website: https://cannabinoids.huji.ac.il/…
مرحبًا بك في مشغل أف ام!
يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.